Literature DB >> 20001425

Treatment strategies for dystonia.

Leslie J Cloud1, H A Jinnah.   

Abstract

IMPORTANCE OF THE FIELD: Dystonia is a neurological syndrome characterized by involuntary twisting movements and unnatural postures. It has many different manifestations and causes, and many different treatment options are available. These options include physical and occupational therapy, oral medications, intramuscular injection of botulinum toxins, and neurosurgical interventions. AREAS COVERED IN THIS REVIEW: In this review, we first summarize the treatment options available, then we provide suggestions from our own experience for how these can be applied in different types of dystonia. In preparing this review article, an extensive literature search was undertaken using PubMed. Only selected references from 1970 to 2008 are cited. WHAT THE READER WILL GAIN: This review is intended to provide the clinician with a practical guide to the treatment of dystonia. TAKE HOME MESSAGE: Treatment of dystonia begins with proper diagnosis and classification, followed by an appropriate search for underlying etiology, and an assessment of the functional impairment associated with the dystonia. The therapeutic approach, which is usually limited to symptomatic therapy, must then be tailored to the individual needs of the patient.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20001425      PMCID: PMC3495548          DOI: 10.1517/14656560903426171

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  93 in total

1.  Long-term effects of tetrabenazine in hyperkinetic movement disorders.

Authors:  J Jankovic; J Beach
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

2.  Response and immunoresistance to botulinum toxin injections.

Authors:  J Jankovic; K Schwartz
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910

Review 3.  Medical therapy and botulinum toxin in dystonia.

Authors:  J Jankovic
Journal:  Adv Neurol       Date:  1998

4.  A pilot trial of clozapine in the treatment of cervical dystonia.

Authors:  P Burbaud; D Guehl; A Lagueny; F Petiteau; B Bioulac
Journal:  J Neurol       Date:  1998 Jun-Jul       Impact factor: 4.849

5.  Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.

Authors:  S L Pullman; P Greene; S Fahn; S F Pedersen
Journal:  Arch Neurol       Date:  1996-07

6.  Efficacy of risperidone in idiopathic segmental dystonia.

Authors:  A Zuddas; C Cianchetti
Journal:  Lancet       Date:  1996-01-13       Impact factor: 79.321

Review 7.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

8.  Use of intrathecal baclofen in the treatment of patients with dystonia.

Authors:  B Ford; P Greene; E D Louis; G Petzinger; S B Bressman; R Goodman; M F Brin; S Sadiq; S Fahn
Journal:  Arch Neurol       Date:  1996-12

9.  Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene.

Authors:  H Ichinose; T Ohye; E Takahashi; N Seki; T Hori; M Segawa; Y Nomura; K Endo; H Tanaka; S Tsuji
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

Review 10.  Clonazepam-sensitive intermittent dystonic tremor.

Authors:  T L Davis; P D Charles; R S Burns
Journal:  South Med J       Date:  1995-10       Impact factor: 0.954

View more
  26 in total

Review 1.  Dystonia rating scales: critique and recommendations.

Authors:  Alberto Albanese; Francesca Del Sorbo; Cynthia Comella; H A Jinnah; Jonathan W Mink; Bart Post; Marie Vidailhet; Jens Volkmann; Thomas T Warner; Albert F G Leentjens; Pablo Martinez-Martin; Glenn T Stebbins; Christopher G Goetz; Anette Schrag
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 2.  Diagnosis and treatment of dystonia.

Authors:  H A Jinnah; Stewart A Factor
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

3.  Functional activity of the sensorimotor cortex and cerebellum relates to cervical dystonia symptoms.

Authors:  Roxana G Burciu; Christopher W Hess; Stephen A Coombes; Edward Ofori; Priyank Shukla; Jae Woo Chung; Nikolaus R McFarland; Aparna Wagle Shukla; Michael S Okun; David E Vaillancourt
Journal:  Hum Brain Mapp       Date:  2017-06-08       Impact factor: 5.038

4.  TorsinA restoration in a mouse model identifies a critical therapeutic window for DYT1 dystonia.

Authors:  Jay Li; Daniel S Levin; Audrey J Kim; Samuel S Pappas; William T Dauer
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

5.  Prevalence, predictors, and perceived effectiveness of complementary, alternative and integrative medicine in adult-onset primary dystonia.

Authors:  Brandy M Fleming; Emiko L Schwab; Simonne S Nouer; Jim Y Wan; Mark S LeDoux
Journal:  Parkinsonism Relat Disord       Date:  2012-05-25       Impact factor: 4.891

Review 6.  The neurobiological basis for novel experimental therapeutics in dystonia.

Authors:  Anthony M Downs; Kaitlyn M Roman; Simone A Campbell; Antonio Pisani; Ellen J Hess; Paola Bonsi
Journal:  Neurobiol Dis       Date:  2019-07-04       Impact factor: 5.996

Review 7.  Movement disorders of the mouth: a review of the common phenomenologies.

Authors:  C M Ghadery; L V Kalia; B S Connolly
Journal:  J Neurol       Date:  2022-07-29       Impact factor: 6.682

8.  Perceptual decisions based on previously learned information are independent of dopaminergic tone.

Authors:  Alessandra Perugini; Michele A Basso
Journal:  J Neurophysiol       Date:  2017-11-22       Impact factor: 2.714

9.  A Systematic Review of Long-Interval Intracortical Inhibition as a Biomarker in Neuropsychiatric Disorders.

Authors:  Parmis Fatih; M Utku Kucuker; Jennifer L Vande Voort; Deniz Doruk Camsari; Faranak Farzan; Paul E Croarkin
Journal:  Front Psychiatry       Date:  2021-06-02       Impact factor: 4.157

Review 10.  Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.

Authors:  Brent Bluett; Alexander Y Pantelyat; Irene Litvan; Farwa Ali; Diana Apetauerova; Danny Bega; Lisa Bloom; James Bower; Adam L Boxer; Marian L Dale; Rohit Dhall; Antoine Duquette; Hubert H Fernandez; Jori E Fleisher; Murray Grossman; Michael Howell; Diana R Kerwin; Julie Leegwater-Kim; Christiane Lepage; Peter Alexander Ljubenkov; Martina Mancini; Nikolaus R McFarland; Paolo Moretti; Erica Myrick; Pritika Patel; Laura S Plummer; Federico Rodriguez-Porcel; Julio Rojas; Christos Sidiropoulos; Miriam Sklerov; Leonard L Sokol; Paul J Tuite; Lawren VandeVrede; Jennifer Wilhelm; Anne-Marie A Wills; Tao Xie; Lawrence I Golbe
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.